Human Vascular Endothelial Cells Catabolise Exogenous Glycosaminoglycans by a Novel Route

Summary

Heparin and other anticoagulant glycosaminoglycans were radiolabelled with ¹²⁵I and their catabolism by human vascular endothelial cells in culture was studied. Heparin, heparan sulphate and pentosan polysulphate were associated with the cellular fraction and incorporated into the subendothelial matrix, but dermatan sulphate was not found in either fraction. High molecular weight, fully desulphated carbohydrate chains were major catabolic products of all those glycosaminoglycans which were taken up by the cells. Pentosan polysulphate was not degraded further, but the catabolism of heparan sulphate, and to a lesser extent that of heparin, also yielded small oligosaccharides. Thus the first step in catabolism of exogenous glycosaminoglycans by human vascular endothelial cells appears to be complete desul-phation, which destroys their biological activity, followed by depolymerisation of the carbohydrate chain. This alternative to the sequential action of lysosomal exoenzymes is dependent upon binding to the cell; thus dermatan sulphate, which is not associated with the cellular fraction, is not catabolised.

• References

• 1 Marcum JA, Rosenberg RD. Heparinlike molecules with anticoagulant activity are synthesised by cultured endothelial cells. Biochem Biophys Res Commun 1985; 126: 365-372
• 2 Dawes J, Hodson BA, Pepper DS. The absorption, clearance and metabolic fate of dermatan sulphate administered to man - studies using a radioiodinated derivative. Thromb Haemostas 1989; 62: 945-949
• 3 Hopwood JJ, Morris CP. The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment. Mol Biol Med 1990; 7: 381-104
• 4 Wasteson A, Hook M, Westermark B. Demonstration of a platelet enzyme, degrading heparan sulphate. FEBS Lett 1976; 64: 218-221
• 5 Klein U, von Figura K. Partial purification and characterization of a heparan sulphate specific endoglucuronidase. Biochem Biophys Res Commun 1976; 73: 569-576
• 6 Naparstek Y, Cohen IR, Fuks Z, Vlodavsky I. Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature 1984; 310: 241-244
• 7 Barzu T, Molho P, Tobelem G, Petitou M, Caen J. Binding and endocytosis of heparin by human endothelial cells in culture. Biochim Biophys Acta 1985; 845: 196-203
• 8 Vannucchi S, Pasquali F, Porciatti F, Chiarugi V, Magnelli L, Bianchini P. Binding, internalization and degradation of heparin and heparin fragments by cultured endothelial cells. Thromb Res 1988; 49: 373-383
• 9 Dawes J, Pepper DS. Catabolism of low dose heparin in man. Thromb Res 1979; 14: 845-860
• 10 MacGregor IR, Dawes J, Paton L, Pepper DS, Prowse CV, Smith M. Metabolism of sodium pentosan polysulphate in man - catabolism of iodinated derivatives. Thromb Haemostas 1984; 51: 321-325
• 11 Dawes J. Measurement of the affinities of heparins, naturally occurring glycosaminoglycans and other sulphated polymers for antithrombin III and thrombin. Anal Biochem 1988; 174: 177-186
• 12 Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 1979; 76: 5674-5678
• 13 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756
• 14 Lam LH, Silbert JE, Rosenberg RD. The separation of active and inactive forms of heparin. Biochem Biophys Res Commun 1976; 69: 570-577
• 15 Shively JE, Conrad HE. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 1976; 15: 3932-3942
• 16 Barzu T, van Rijn JLML, Petitou M, Molho P, Tobelem G, Caen J. Endothelial binding sites for heparin. Specificity and role in heparin neutralization. Biochem J 1986; 238: 847-854
• 17 Barzu T, van Rijn JLML, Petitou M, Tobelem G, Caen J. Heparin degradation in the endothelial cells. Thromb Res 1987; 47: 601-609
• 18 Perry MA, Powell GM, Wusteman FS, Curtis CG. The catabolism of intravenously injected V-[³⁵S]sulphate in the rat. Biochem J 1977; 166: 373-379
• 19 Nakamura T, Takagaki K, Majima M, Kimura S, Kubo K, Endo M. A new type of exo-p-glucuronidase acting only on non-sulfated gly-cosaminoglycans. J Biol Chem 1990; 265: 5390-5397
• 20 Muir H. Structure and enzymic degradation of mucopolysaccharides. In: Lysosomes and Storage Diseases. Hers HG, Van Hoof F. (eds) Academic Press; London: 1973. pp 79-104